Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.040
-0.040 (-3.70%)
At close: Aug 29, 2025, 4:00 PM
1.050
+0.010 (0.96%)
After-hours: Aug 29, 2025, 6:46 PM EDT

Fate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1201883699805,5877,933
Upgrade
Market Cap Growth
-65.61%-49.04%-62.39%-82.45%-29.57%436.26%
Upgrade
Enterprise Value
-22-101245865,0187,530
Upgrade
Last Close Price
1.041.653.7410.0958.5190.93
Upgrade
PS Ratio
14.5213.795.8010.18100.05252.37
Upgrade
PB Ratio
0.460.591.002.038.2320.64
Upgrade
P/TBV Ratio
0.460.591.002.038.2320.64
Upgrade
EV/Sales Ratio
--1.956.0989.85239.54
Upgrade
Debt / Equity Ratio
0.310.270.280.230.170.25
Upgrade
Asset Turnover
0.020.030.110.120.070.07
Upgrade
Quick Ratio
7.897.398.134.177.705.73
Upgrade
Current Ratio
8.047.588.484.407.795.78
Upgrade
Return on Equity (ROE)
-52.11%-54.21%-37.76%-48.46%-39.91%-55.11%
Upgrade
Return on Assets (ROA)
-24.66%-25.81%-19.65%-23.69%-17.57%-17.31%
Upgrade
Return on Capital (ROIC)
-26.43%-27.90%-22.36%-27.79%-21.27%-21.25%
Upgrade
Earnings Yield
-143.00%-99.11%-43.64%-28.73%-3.80%-2.19%
Upgrade
FCF Yield
-99.02%-65.77%-37.53%-28.94%-3.82%-0.56%
Upgrade
Buyback Yield / Dilution
-13.79%-15.52%-1.64%-2.19%-15.00%-20.82%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q